aplastic anemia | Page 31 | Aplastic Anemia and MDS International Foundation

aplastic anemia

Aplastic Anemia & MDS International Foundation: Bone marrow failure disease scientific symposium 2012

Author(s): 
Savage SA, Pulsipher MA, Romano A, Berlyne D.
Primary Author: 
Savage SA
Journal Title: 
Leuk Res
Original Publication Date: 
May 2013

The decision to pursue hematopoietic stem cell transplantation or immunosuppression as first therapy in severe

Bone Marrow Diseases: 

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.

Author(s): 
Townsley DM, Desmond R, Dunbar CE, Young NS.
Primary Author: 
Townsley DM
Journal Title: 
Int J Hematol
Original Publication Date: 
May 2013

Bone Marrow Diseases: 

Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.

Author(s): 
Chung NG, Lee JW, Jang PS, Jeong DC, Cho B, Kim HK
Primary Author: 
Chung NG
Journal Title: 
Pediatr Transplant
Original Publication Date: 
Apr 2013

We evaluated the results of a novel conditioning regimen of reduced dose

Bone Marrow Diseases: 

Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

Author(s): 
Hussein AA, Frangoul H
Primary Author: 
Hussein AA
Journal Title: 
Pediatr Transplant
Original Publication Date: 
Apr 2013

No abstract available.

Bone Marrow Diseases: